Matthias Bodenstedt
Director of Finance/CFO en MOONLAKE IMMUNOTHERAPEUTICS .
Fortuna: 41 M $ al 31/03/2024
Perfil
Matthias Bodenstedt is currently the Director and Chief Financial Officer at Moonlake Immunotherapeutics Ltd., Moonlake Immunotherapeutics AG, and MoonLake Immunotherapeutics.
Prior to this, he worked as a Partner at McKinsey & Co., Inc. from 2015 to 2021.
Bodenstedt received his undergraduate degree from the University of Hannover, his graduate degree from the University of Cambridge, and his MBA from Columbia Business School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/12/2023 | 520 903 ( 0.87% ) | 26 M $ | 31/03/2024 | |
| 01/10/2023 | 294 473 ( 3.29% ) | 15 M $ | 31/03/2024 |
Cargos activos de Matthias Bodenstedt
| Empresas | Cargo | Inicio |
|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Director of Finance/CFO | 05/04/2022 |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The private company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Director of Finance/CFO | 01/07/2021 |
| Moonlake Immunotherapeutics Ltd. | Director/Board Member | 01/09/2021 |
Antiguos cargos conocidos de Matthias Bodenstedt.
| Empresas | Cargo | Fin |
|---|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/06/2021 |
Formación de Matthias Bodenstedt.
| University of Cambridge | Graduate Degree |
| University of Hannover | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
| Empresas privadas | 3 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The private company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
| Moonlake Immunotherapeutics Ltd. |
- Bolsa de valores
- Insiders
- Matthias Bodenstedt
